You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

consilium care

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial (consilium care™ app)

Not yet recruiting
  • Breast Cancer
  • consilium care™ app
  • (no location specified)
Jun 16, 2022

Advanced Breast Cancer Trial in Moldova, Republic of, United States (Lerociclib + Letrozole or Fulvestrant)

Recruiting
  • Advanced Breast Cancer
  • Lerociclib + Letrozole or Fulvestrant
  • Jacksonville, Florida
  • +16 more
Dec 15, 2022

Breast Cancer Trial in Georgia, United States (entinostat, atezolizumab, Placebo)

Completed
  • Breast Cancer
  • Birmingham, Alabama
  • +28 more
May 9, 2022

"Consilium" Smartphone App for Detecting Symptoms and Treatment

Terminated
  • Telemedicine
  • eHealth
  • app
  • Feldkirch, Austria
  • +17 more
Jan 31, 2022

Chronic Pancreatitis Trial in Russian Federation, Ukraine, United States (NI-03, Placebo)

Completed
  • Chronic Pancreatitis
  • Little Rock, Arkansas
  • +47 more
Dec 14, 2022

Systemic Lupus Erythematosus Trial in Worldwide (BOS161721, Placebo)

Completed
Has Results
  • Systemic Lupus Erythematosus
  • Anniston, Alabama
  • +67 more
Feb 16, 2022

Dyslipidemias, Hypertension Trial in Georgia, Russian Federation, Ukraine (Atorvastatin/Perindopril, Atorvastatin, Perindopril)

Terminated
  • Dyslipidemias
  • Hypertension
  • Kutaisi, Georgia
  • +41 more
Dec 2, 2022

Endometrial Cancer Trial in Worldwide (retifanlimab, epacadostat, pemigatinib)

Recruiting
  • Endometrial Cancer
  • Anchorage, Alaska
  • +78 more
Jul 25, 2022

Ulcerative Colitis Trial in Worldwide (GB004, Placebo)

Terminated
  • Ulcerative Colitis
  • Encinitas, California
  • +76 more
Aug 17, 2022

HER2-directed Biosimilar in Breast Cancer: Real World ePRO

Recruiting
  • HER2-positive Breast Cancer
  • +2 more
    • Horgen, Zurich, Switzerland
    • +4 more
    Oct 3, 2022

    Migraine Trial in Georgia, United States (Eptinezumab, Placebo)

    Completed
    Has Results
    • Migraine
    • Birmingham, Alabama
    • +56 more
    Aug 13, 2021

    Cervical Cancer Trial in Worldwide (biological, drug, other)

    Recruiting
    • Cervical Cancer
    • BCD-100
    • +4 more
    • Shanghai, China
    • +25 more
    Sep 16, 2020

    Lupus Erythematosus, Systemic Trial in Worldwide (VIB7734, Placebo)

    Active, not recruiting
    • Lupus Erythematosus, Systemic
    • La Jolla, California
    • +88 more
    Jan 10, 2023

    Respiratory Syncytial Virus Trial in Worldwide (EDP-938, Placebo)

    Completed
    • Respiratory Syncytial Virus
    • Birmingham, Alabama
    • +106 more
    Feb 9, 2022

    Colitis, Ulcerative Trial in Worldwide (LY3471851, Placebo)

    Terminated
    • Colitis, Ulcerative
    • Litchfield Park, Arizona
    • +115 more
    Aug 17, 2022

    Crohn's Disease Trial in Worldwide (Mirikizumab)

    Recruiting
    • Crohn's Disease
    • Dothan, Alabama
    • +318 more
    Jan 18, 2023

    Advanced or Inoperable Gastric Cancer Trial in Worldwide (pamiparib, Placebo)

    Completed
    • Advanced or Inoperable Gastric Cancer
    • Santa Rosa, California
    • +140 more
    Jan 10, 2023

    Cluster Headache, Episodic Trial in Worldwide (Eptinezumab, Placebo)

    Recruiting
    • Cluster Headache, Episodic
    • Phoenix, Arizona
    • +110 more
    Jul 12, 2022

    TNBC - Triple-Negative Breast Cancer, Breast Cancer Trial in Worldwide (Trilaciclib, Placebo, Gemcitabine)

    Active, not recruiting
    • TNBC - Triple-Negative Breast Cancer
    • Breast Cancer
    • Birmingham, Alabama
    • +111 more
    Oct 25, 2022

    Platinum-resistant Ovarian Cancer Trial in Worldwide (Batiraxcept, Paclitaxel, Placebo)

    Recruiting
    • Platinum-resistant Ovarian Cancer
    • Mobile, Alabama
    • +149 more
    Dec 9, 2022

    NSCLC, NSCLC Trial in Worldwide (Tislelizumab, Ociperlimab, Pembrolizumab)

    Recruiting
    • Non-small Cell Lung Cancer
    • NSCLC
    • Birmingham, Alabama
    • +223 more
    May 24, 2022

    Ulcerative Colitis Trial in Worldwide (Mirikizumab)

    Recruiting
    • Ulcerative Colitis
    • Dothan, Alabama
    • +350 more
    Jan 18, 2023

    Crohn's Disease Trial in Worldwide (Mirikizumab, Ustekinumab, Placebo)

    Recruiting
    • Crohn's Disease
    • Birmingham, Alabama
    • +580 more
    Aug 17, 2022

    Rheumatoid Arthritis (RA) Trial in Worldwide (ABBV-154, Placebo)

    Active, not recruiting
    • Rheumatoid Arthritis (RA)
    • Phoenix, Arizona
    • +222 more
    Jun 7, 2022

    Rheumatoid Arthritis Trial in Worldwide (PF-06650833, PF-06651600, Tofacitinib)

    Completed
    • Rheumatoid Arthritis
    • Pleven, Bulgaria
    • +143 more
    Mar 2, 2022